NDC 71894-115 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-115
- Package NDCs from labels
- 71894-115-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 107.9 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 58.1 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 74.7 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 24.9 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 91.3 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 99.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 91.3 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 16.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 41.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 8.3 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 24.9 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 107.9 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 66.4 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 33.2 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 99.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 33.2 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 83 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 16.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 16.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 66.4 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 58.1 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 58.1 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 74.7 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 91.3 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 41.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 41.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 99.6 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 49.8 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 33.2 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 49.8 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 74.7 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 49.8 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 66.4 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 83 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 24.9 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 83 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-115-01 | Zolgensma | 8.3 mL in 1 VIAL | INJECTION, SUSPENSION | 116.2 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 70% | ISOPROPYL ALCOHOL | Your Military Exchanges | 3dcb8422-827d-479b-ba18-eee8dbb762e1 | 2026-04-30 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Perrigo Direct, Inc | 11d89d11-103e-4ef6-a996-65cff67f9b32 | 2026-04-29 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Walmart Inc. | 1fd3d29f-7da0-c5ba-e063-6294a90add16 | 2026-04-29 | Warnings, Adverse reactions | ND2M416302 |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| leuprolide acetate | LEUPROLIDE ACETATE | Sun Pharmaceutical Industries, Inc. | a3b01473-30c7-4945-bd60-2484221aaaad | 2026-04-24 | Warnings, Adverse reactions | 797544 |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Meitheal Pharmaceuticals Inc | d6bd26bd-b8d8-4c5a-bc5c-7b8a1efaa584 | 2026-04-23 | Warnings, Adverse reactions | 797544 |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| 3M DuraPrep Surgical | IODINE POVACRYLEX AND ISOPROPYL ALCOHOL | Solventum US LLC | 22a10a54-6a04-48b3-9ec4-b26526183daf | 2026-04-23 | Warnings | ND2M416302 |
| 3M SoluPrep S | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | Solventum US LLC | 084aa305-5863-441a-a94d-36bc1b05195a | 2026-04-23 | Warnings | ND2M416302 |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| ALCOHOL PREP PADS LARGE STERILE | ISOPROPYL ALCOHOL CLOTH | JINHUA JINGDI MEDICAL SUPPLIES CO.,LTD | 4f8ba6c8-5155-c491-e063-6394a90adde9 | 2026-04-15 | Warnings | 797544 ND2M416302 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.